SMTL ID : 6l9n.2 (3 other biounits)

H2-Ld complexed with A5 peptide

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

hetero-1-1-mer

Ligands

1 x SER- PRO- SER- TYR- ALA- TYR- HIS- GLN- PHE: SER-PRO-SER-TYR-ALA-TYR-HIS-GLN-PHE(Non-covalent)

SER-PRO-SER-TYR-ALA-TYR-HIS-GLN-PHE.1: 29 residues within 4Å: Chain A: M.6, Y.8, Y.46, R.63, I.64, Q.66, I.67, G.70, Q.71, W.74, V.77, N.78, T.81, L.82, Y.85, L.96, W.98, Y.100, F.117, Y.124, T.144, K.147, W.148, A.153, Y.156, Y.157, Y.160, W.168, Y.172 29 PLIP interactions: 29 interactions with chain A Hydrophobic interactions: A:Y.8, A:Y.46, A:I.64, A:W.74, A:W.74, A:N.78, A:L.82, A:L.96, A:W.98, A:F.117, A:Y.124, A:Y.124, A:T.144, A:W.148, A:Y.156 Hydrogen bonds: A:Y.8, A:R.63, A:R.63, A:Q.71, A:Q.71, A:N.78, A:N.78, A:Y.100, A:Y.100, A:Y.156, A:Y.156, A:Y.172, A:Y.172 Salt bridges: A:K.147

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wei, P. et al., Structures suggest an approach for converting weak self-peptide tumor antigens into superagonists for CD8 T cells in cancer. Proc.Natl.Acad.Sci.USA (2021)

Release Date

2020-11-18

Peptides

MHC: A
b2m: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
D

B
E

MHC

b2m

Related Entries With Identical Sequence